Treatment completion for latent tuberculosis infection in Norway: a prospective cohort study.
Yvette Louise ScheinTesfaye MadeboHilde Elise AndersenTrude Margrete ArnesenAnne Ma Dyrhol-RiiseHallgeir TveitenRichard A WhiteBrita Askeland WinjePublished in: BMC infectious diseases (2018)
We report a very high treatment completion rate, especially among individuals from countries with high TB incidence. The follow-up from tuberculosis-coordinators and the frequent use of directly observed treatment probably contributes to this. Few severe adverse events were reported, even with increased age and in individuals that are more susceptible. While these results are promising, issues of cost-effectiveness and targeting treatment to individuals at highest risk of TB are important components of public health impact.